Sangamo Therapeutics
SGMO
SGMO
129 hedge funds and large institutions have $31.1M invested in Sangamo Therapeutics in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
1.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
33
Reduced
44
Closed
28
Calls
$29K
Puts
$60K
Net Calls
-$31K
Net Calls Change
+$44K
Top Buyers
| 1 |
1
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.06M |
| 2 |
2
Renaissance Technologies
New York
|
$1.48M |
| 3 |
3
Millennium Management
New York
|
$863K |
| 4 |
YIH
4
Y-Intercept (HK)
Hong Kong
|
$267K |
| 5 |
5
Goldman Sachs
New York
|
$478K |
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.69M |
| 2 |
AC
2
Armistice Capital
New York
|
$5.04M |
| 3 |
3
Mirae Asset Global Investments
Seoul,
South Korea
|
$0 |
| 4 |
4
State Street
Boston,
Massachusetts
|
$186K |
| 5 |
5
D.E. Shaw & Co
New York
|
$418K |
